Range Low Price High Price Comment
30 days $71.92 $76.20 Thursday, 28th Mar 2024 GILD stock ended at $73.25. This is 0.329% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 0.92% from a day low at $73.20 to a day high of $73.87.
90 days $71.37 $87.86
52 weeks $71.37 $87.86

Historical Gilead Sciences prices

Date Open High Low Close Volume
2024-03-28 $73.25 $73.87 $73.20 $73.25 8 242 895
2024-03-27 $72.92 $73.06 $72.55 $73.01 7 734 770
2024-03-26 $72.32 $72.66 $72.11 $72.41 5 214 118
2024-03-25 $72.50 $72.84 $72.20 $72.58 5 479 485
2024-03-22 $73.11 $73.23 $72.56 $72.61 7 665 569
2024-03-21 $73.90 $74.28 $73.03 $73.09 5 810 324
2024-03-20 $73.27 $73.98 $72.80 $73.98 7 060 619
2024-03-19 $73.34 $73.77 $73.19 $73.41 6 497 629
2024-03-18 $73.69 $74.17 $73.21 $73.26 5 382 761
2024-03-15 $74.25 $74.66 $73.29 $73.69 13 896 205
2024-03-14 $74.72 $75.02 $73.82 $74.21 7 360 492
2024-03-13 $75.49 $76.18 $74.96 $75.94 5 971 378
2024-03-12 $75.25 $75.32 $74.26 $75.08 6 012 488
2024-03-11 $74.88 $76.20 $74.83 $75.32 7 391 111
2024-03-08 $73.96 $75.44 $73.67 $75.12 8 876 299
2024-03-07 $72.97 $74.08 $72.68 $73.66 9 424 031
2024-03-06 $72.88 $73.32 $72.51 $72.63 6 125 434
2024-03-05 $72.40 $73.01 $72.10 $72.99 5 867 977
2024-03-04 $72.39 $72.60 $71.96 $72.25 4 951 622
2024-03-01 $72.28 $72.66 $72.04 $72.31 5 317 015
2024-02-29 $72.72 $72.91 $71.92 $72.10 8 538 012
2024-02-28 $73.18 $73.25 $72.62 $72.70 4 173 905
2024-02-27 $72.85 $73.14 $72.63 $73.02 6 056 844
2024-02-26 $73.50 $73.88 $72.84 $72.95 5 175 893
2024-02-23 $73.25 $74.24 $73.00 $73.55 5 563 321
Click to get the best stock tips daily for free!

About Gilead Sciences

Gilead Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT